0001123292-17-001465.txt : 20171002
0001123292-17-001465.hdr.sgml : 20171002
20171002165438
ACCESSION NUMBER: 0001123292-17-001465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170928
FILED AS OF DATE: 20171002
DATE AS OF CHANGE: 20171002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graff Fred
CENTRAL INDEX KEY: 0001667407
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 171115099
MAIL ADDRESS:
STREET 1: C/O RECRO PHARMA, INC.
STREET 2: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-09-28
0001588972
Recro Pharma, Inc.
REPH
0001667407
Graff Fred
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
0
1
0
0
Chief Commercial Officer
Common Stock
2017-09-28
4
M
0
2000
A
10000
D
On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,000 performance-based restricted stock units, which were converted into 2,000 shares of common stock on a one-for-one basis.
/s/ Ryan D. Lake, attorney-in-fact
2017-10-02